Northwest Biotherapeutics Inc (NASDAQ:NWBO)

7.37
Delayed Data
As of Mar 31
 -0.09 / -1.21%
Today’s Change
3.79
Today|||52-Week Range
9.35
+37.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization3.0K3.0K3.0K346.0K
 
 
 
 
 
 
Operating ExpensesGross Income-3.0K-3.0K-3.0K-346.0K
 
 
 
 
 
General Expenses14.7M23.7M25.4M26.8M
 
 
 
 
 
Research And Development11.1M20.0M21.5M22.7M
 
 
 
 
 
Total Operating Expenses14.7M23.7M25.4M27.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.7M-23.7M-25.4M-27.2M
 
 
 
 
 
Extraordinary Credit1.1M--4.7M14.0M
 
 
 
 
Extraordinary Charge-3.1M-22.2M-5.1M--
 
 
 
 
Interest Expense On Debt167.0K122.0K33.0K271.0K
 
 
 
 
 
Other Expenses3.0K-2.0K0.00-7.6M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.9M-46.0M-25.9M-21.0M
 
 
 
 
 
Net Income-16.9M-46.0M-25.9M-21.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.2M52.4M57.4M60.6M
 
 
 
 
 
Shares To Calculate EPS Diluted42.2M52.4M57.4M60.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.88-$0.45-$0.35
 
 
 
 
 
EPS Diluted-$0.40-$0.88-$0.45-$0.35
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account